BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17224231)

  • 1. Is the polycystic ovary syndrome associated with chronic inflammation per se?
    Olszanecka-Glinianowicz M; Banaś M; Zahorska-Markiewicz B; Janowska J; Kocełak P; Madej P; Klimek K
    Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):197-202. PubMed ID: 17224231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of weight loss on inflammation in obese women with polycystic ovary syndrome.
    Olszanecka-Glinianowicz M; Zahorska-Markiewicz B; Kocełak P; Janowska J; Semik-Grabarczyk E
    Endokrynol Pol; 2008; 59(1):13-7. PubMed ID: 18335395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there an interaction between polycystic ovary syndrome and gingival inflammation?
    Özçaka Ö; Ceyhan BÖ; Akcali A; Biçakci N; Lappin DF; Buduneli N
    J Periodontol; 2012 Dec; 83(12):1529-37. PubMed ID: 22509751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.
    Vgontzas AN; Trakada G; Bixler EO; Lin HM; Pejovic S; Zoumakis E; Chrousos GP; Legro RS
    Metabolism; 2006 Aug; 55(8):1076-82. PubMed ID: 16839844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.
    Safranow K; Dziedziejko V; Rzeuski R; Czyzycka E; Wojtarowicz A; Bińczak-Kuleta A; Jakubowska K; Olszewska M; Ciechanowicz A; Kornacewicz-Jach Z; Machaliński B; Pawlik A; Chlubek D
    Tissue Antigens; 2009 Nov; 74(5):386-92. PubMed ID: 19845893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome.
    González F; Rote NS; Minium J; Kirwan JP
    J Endocrinol; 2006 Mar; 188(3):521-9. PubMed ID: 16522732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity.
    Słopień R; Lewandowski K; Kolacz E; Zawilska K; Warenik-Szymankiewicz A
    Gynecol Endocrinol; 2006 Nov; 22(11):651-4. PubMed ID: 17145652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance.
    Janowska J; Zahorska-Markiewicz B; Olszanecka-Glinianowicz M
    Metabolism; 2006 Nov; 55(11):1495-9. PubMed ID: 17046552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
    Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor necrosis factor alpha is higher in non-obese, non-diabetic Mexican Americans compared to non-Hispanic white adults.
    Ho RC; Davy KP; Hickey MS; Melby CL
    Cytokine; 2005 Apr; 30(1):14-21. PubMed ID: 15784408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure.
    Conraads VM; Denollet J; De Clerck LS; Stevens WJ; Bridts C; Vrints CJ
    Int J Cardiol; 2006 Oct; 113(1):34-8. PubMed ID: 16325284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome.
    Benson S; Janssen OE; Hahn S; Tan S; Dietz T; Mann K; Pleger K; Schedlowski M; Arck PC; Elsenbruch S
    Brain Behav Immun; 2008 Feb; 22(2):177-84. PubMed ID: 17716857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
    Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women with polycystic ovary syndrome are sensitive to the TNF-alpha-lowering effect of glucose-induced hyperinsulinaemia.
    Puder JJ; Varga S; Nusbaumer CP; Zulewski H; Bilz S; Müller B; Keller U
    Eur J Clin Invest; 2006 Dec; 36(12):883-9. PubMed ID: 17087783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
    Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
    Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of Type D personality and kidney dysfunction as predictors of interpatient variability in inflammatory activation in chronic heart failure.
    Denollet J; Schiffer AA; Kwaijtaal M; Hooijkaas H; Hendriks EH; Widdershoven JW; Kupper N
    Am J Cardiol; 2009 Feb; 103(3):399-404. PubMed ID: 19166697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.